Continuous glucose monitoring for babies of mothers with diabetes
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial uses a continuous glucose monitor (a small sensor placed on the skin) to track blood sugar levels in newborns whose mothers used insulin for gestational diabetes. The goal is to see if this monitoring helps prevent low blood sugar in babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are carrying one baby (not twins or more).
- You have gestational diabetes that is treated with insulin.
- Your baby is born at full term (37 weeks or later).
- You did not smoke during this pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a continuous glucose monitor can safely track blood sugar levels in newborns. It may help doctors better understand glucose patterns in babies at birth.
This study checks how well continuous glucose monitors work in newborns. It aims to improve care for babies by making glucose monitoring easier and less invasive.
This study compares two ways to check blood sugar during pregnancy in women with gestational diabetes: a small sensor worn on the skin that tracks glucose continuously, versus traditional finger-stick testing. The goal is to see which method helps women manage their blood sugar better and have healthier pregnancies.
This study compares a continuous glucose monitor (CGM) to standard finger-prick testing for managing gestational diabetes. It aims to see if the CGM can improve blood sugar control and maternal outcomes.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This study uses a continuous glucose monitor to check blood sugar levels after giving birth in people who had gestational diabetes. It aims to find early signs of abnormal blood sugar and may help you understand your risk for type 2 diabetes.
Hear when a new Neonatal Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.